# Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation

> **NCT00460629** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Hospital Carl Gustav Carus** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **PROCEDURE:** Application of activated donor T cells

## Key facts

- **NCT ID:** NCT00460629
- **Lead sponsor:** University Hospital Carl Gustav Carus
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2011-12
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00460629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00460629, "Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00460629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*